Zhao, Ying-Chun <br/><br/>
Clinical significance of Smac and survivin expression in breast cancer patients treated with anthracycline‑based neoadjuvant chemotherapy.  [electronic resource] 

 -  Molecular medicine reports  Feb 2014 
 - 614-20 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-3004 
<br/><br/><label>Standard No.: </label>10.3892/mmr.2013.1842  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anthracyclines--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Apoptosis Regulatory Proteins<br/>Biopsy<br/>Breast Neoplasms--drug therapy<br/>Disease-Free Survival<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Inhibitor of Apoptosis Proteins--biosynthesis<br/>Intracellular Signaling Peptides and Proteins--biosynthesis<br/>Middle Aged<br/>Mitochondrial Proteins--biosynthesis<br/>Neoadjuvant Therapy<br/>Neoplasm Staging<br/>Prognosis<br/>Proportional Hazards Models<br/>Receptors, Estrogen--genetics<br/>Survivin